Title: Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.
Journal: Molecular cancer therapeutics 20140401
144171-61-9 | Indeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylic acid, 7-chloro-2,5-dihydro-2-[[(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]amino]carbonyl]-, methyl ester | AA001IZC | MFCD03792834
1445-79-0 | Gallium, trimethyl- | AA001JKD | MFCD00014841
144689-24-7 | Olmesartan | AA001JXM | MFCD00914967
14496-33-4 | N-(Furan-2-ylmethyl)ethanamine | AA001KBH | MFCD00069030
145224-94-8 | Mes monohydrate | AA001KMC | MFCD00149409
1485-19-4 | 9-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one | AA001KW0 | MFCD00230526
1489-97-0 | Ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate | AA001L7E | MFCD00205582
1493-27-2 | 1-Fluoro-2-nitrobenzene | AA001LHI | MFCD00007048
1496-78-2 | 1H-Indole, 3-bromo-2-methyl- | AA001LSG | MFCD00982985
149961-52-4 | Benzeneacetamide, 2-[(2,5-dimethylphenoxy)methyl]-α-(methoxyimino)-N-methyl-, (αE)- | AA001M2Z | MFCD05664707